About this Medicine article
Impact of TP53 and KRAS mutations on cisplatin-based adjuvant chemotherapy in non-small-cell lung cancer by X. Ma; E. Brambilla; J.C. Soria; A. Dunant; A.L. Vataire; P. Hainaut; the IALT-Bio study group is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- X. Ma; E. Brambilla; J.C. Soria; A. Dunant; A.L. Vataire; P. Hainaut; the IALT-Bio study group
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
- Published
- 2008
- Language
- EN
- Field
- Medicine (Health Sciences)